Stanford researchers probe Ketamine's Mind-Altering effects in epilepsy patients
NCT ID NCT04861051
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand how ketamine causes dissociative symptoms—feelings of detachment from oneself or reality—in people with epilepsy. Researchers will give ketamine to 20 adults staying in Stanford's epilepsy monitoring unit and measure their dissociative experiences using a standard questionnaire. The goal is purely to learn more about how these effects happen, not to treat epilepsy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University School of Medicine
RECRUITINGPalo Alto, California, 94305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?
- Can a new drug tame severe childhood epilepsy?